These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36469592)

  • 1. Activation of Phosphodiesterase 3A: New Hope for Cardioprotection.
    Chiong M; Houslay MD; Lavandero S
    Circulation; 2022 Dec; 146(23):1779-1782. PubMed ID: 36469592
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
    Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
    J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phosphodiesterase-4D variants integrate into protein kinase A-based signaling complexes in cardiac and vascular myocytes.
    Raymond DR; Carter RL; Ward CA; Maurice DH
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H263-71. PubMed ID: 19060129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
    Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
    J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
    Burmeister BT; Taglieri DM; Wang L; Carnegie GK
    J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy.
    Rababa'h A; Singh S; Suryavanshi SV; Altarabsheh SE; Deo SV; McConnell BK
    Int J Mol Sci; 2014 Dec; 16(1):218-29. PubMed ID: 25547489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKAP Signaling Islands: Venues for Precision Pharmacology.
    Omar MH; Scott JD
    Trends Pharmacol Sci; 2020 Dec; 41(12):933-946. PubMed ID: 33082006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly synthesized cAMP is integrated at a membrane protein complex signalosome to ensure receptor response specificity.
    Guinzberg R; Díaz-Cruz A; Acosta-Trujillo C; Vilchis-Landeros MM; Vázquez-Meza H; Lozano-Flores C; Chiquete-Felix N; Varela-Echavarría A; Uribe-Carvajal S; Riveros-Rosas H; Piña E
    FEBS J; 2017 Jan; 284(2):258-276. PubMed ID: 27865066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic applications of AKAP disrupting peptides.
    Murabito A; Cnudde S; Hirsch E; Ghigo A
    Clin Sci (Lond); 2020 Dec; 134(24):3259-3282. PubMed ID: 33346357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
    Stefan E; Wiesner B; Baillie GS; Mollajew R; Henn V; Lorenz D; Furkert J; Santamaria K; Nedvetsky P; Hundsrucker C; Beyermann M; Krause E; Pohl P; Gall I; MacIntyre AN; Bachmann S; Houslay MD; Rosenthal W; Klussmann E
    J Am Soc Nephrol; 2007 Jan; 18(1):199-212. PubMed ID: 17135396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ.
    Perino A; Ghigo A; Ferrero E; Morello F; Santulli G; Baillie GS; Damilano F; Dunlop AJ; Pawson C; Walser R; Levi R; Altruda F; Silengo L; Langeberg LK; Neubauer G; Heymans S; Lembo G; Wymann MP; Wetzker R; Houslay MD; Iaccarino G; Scott JD; Hirsch E
    Mol Cell; 2011 Apr; 42(1):84-95. PubMed ID: 21474070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-kinase anchoring proteins: scaffolding proteins in the heart.
    Diviani D; Dodge-Kafka KL; Li J; Kapiloff MS
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1742-53. PubMed ID: 21856912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.
    Fernández-Araujo A; Tobío A; Alfonso A; Botana LM
    Int J Biochem Cell Biol; 2014 Aug; 53():89-101. PubMed ID: 24813785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of ATP receptors, opioid receptors, and AKAP regulation of calcium channels.
    Adler EM
    J Gen Physiol; 2014 Mar; 143(3):313-4. PubMed ID: 24567506
    [No Abstract]   [Full Text] [Related]  

  • 16. Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins.
    Blant A; Czubryt MP
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1161-70. PubMed ID: 22856508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local termination of 3'-5'-cyclic adenosine monophosphate signals: the role of A kinase anchoring protein-tethered phosphodiesterases.
    Stangherlin A; Zaccolo M
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):345-53. PubMed ID: 21654331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKAP signaling complexes: getting to the heart of the matter.
    McConnachie G; Langeberg LK; Scott JD
    Trends Mol Med; 2006 Jul; 12(7):317-23. PubMed ID: 16809066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.
    Begum N; Hockman S; Manganiello VC
    J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
    McCahill A; McSorley T; Huston E; Hill EV; Lynch MJ; Gall I; Keryer G; Lygren B; Tasken K; van Heeke G; Houslay MD
    Cell Signal; 2005 Sep; 17(9):1158-73. PubMed ID: 15905070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.